Aspirin Use in Older Patients With Heart Failure and Coronary Artery Disease
National Prescription Patterns and Relationship With Outcomes
Frederick A. Masoudi, MD, MSPH, FACC*, , , ,*,
Pam Wolfe, MA, MS ,
Edward P. Havranek, MD, FACC*, , ,
Saif S. Rathore, MPH||,
JoAnne M. Foody, MD|| and
Harlan M. Krumholz, MD, FACC ,||,¶,#
* Division of Cardiology, Department of Medicine, Denver Health Medical Center, Denver, Colorado
Division of Cardiology, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado
Division of Geriatric Medicine, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado
Colorado Foundation for Medical Care, Aurora, Colorado
|| Section of Cardiovascular Medicine, Department of Internal Medicine, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
¶ Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
# Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.

View larger version (11K):
[in a new window]
|
Figure 1 Weighted median national rates and ranges of state rates of aspirin prescription for Medicare beneficiaries with heart failure as a function of coronary artery disease (CAD) severity in the U.S., 1998 to 2001 (p value for trend across categories of CAD severity <0.001). MI = myocardial infarction.
|
|
|